Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In United Kingdom
This study is comparing Fluoxetine with placebo for people with Depression in Adolescence, Antidepressant Activity in, or Healthy Participants. Participants receive Fluoxetine or placebo and complete study visits and assessments.
In United KingdomThis observational study is following people with Inflammatory Bowel Diseases or Mental Health Issue to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
In United KingdomThis observational study is following people with Depression - depression, Depression Bipolar, or Treatment Resistant Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In United Kingdom
This summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
Remote / onlineThis summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis study is looking at whether a digital support tool can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments.
Remote / onlineThis study is looking at care and outcomes for people with Psychosis, First Episode Psychosis, or Psychotic Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In United KingdomThis study is looking at whether Cannabidiol (CBD) can help people with Clinical High Risk for Psychosis or Clinical High Risk for Developing Psychosis. Participants take part in Cannabidiol (CBD) and complete follow-up assessments.
In United KingdomThis study is looking at care and outcomes for people with Treatment Resistant Psychosis or Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.